BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
30.5295026
NSE Symbol
MARKSANS
Divident Yield %
0.31
Market Cap
(Rs In Cr.)
11,744
P/E (TTM)
62.45
EPS (TTM)
4.15
Face Value
(Rs)
1
Back
Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
20-May-25   Hrs IST

Net profit of Marksans Pharma rose 15.66% to Rs 90.55 crore in the quarter ended March 2025 as against Rs 78.29 crore during the previous quarter ended March 2024. Sales rose 26.51% to Rs 708.46 crore in the quarter ended March 2025 as against Rs 560.01 crore during the previous quarter ended March 2024.

For the full year,net profit rose 21.32% to Rs 380.58 crore in the year ended March 2025 as against Rs 313.70 crore during the previous year ended March 2024. Sales rose 20.46% to Rs 2622.85 crore in the year ended March 2025 as against Rs 2177.41 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales708.46560.01 27 2622.852177.41 20
OPM %17.7519.58 -20.1521.06 -
PBDT138.84121.33 14 587.35497.80 18
PBT116.09100.28 16 503.97423.53 19
NP90.5578.29 16 380.58313.70 21

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)